Abiomed is a healthcare company focusing on mechanical circulatory support devices, improving blood flow, and assisting the heart's pumping function. The company develops, manufactures, and markets products designed to enable the heart to rest, heal, and recover for patients in need of hemodynamic support before, during, or after angioplasty or heart surgery procedures. These products are used by interventional cardiologists in cardiac catheterization labs and by heart surgeons in heart surgery suites.
Founded in Danvers, Massachusetts, Abiomed is led by CEO Michael R. Minogue and boasts a diverse workforce of 1,536 employees. With an annual revenue of $1.0 billion, the company has a positive reputation for its competitive salaries and excellent retention rates. Abiomed's commitment to innovation in the healthcare sector has led to the development of life-saving technologies and treatments that have greatly impacted the lives of heart failure patients.
